A phase I trial of hepatic arterial bromodeoxyuridine and conformal radiation therapy for patients with primary hepatobiliary cancers or colorectal liver metastases.
about
Feasibility of sorafenib combined with local radiotherapy in advanced hepatocellular carcinomaEffect of Oral Supplementation with Branched-chain Amino Acid (BCAA) during Radiotherapy in Patients with Hepatocellular Carcinoma: A Double-Blind Randomized StudyEthynyldeoxyuridine (EdU) suppresses in vitro population expansion and in vivo tumor progression of human glioblastoma cells.The optimal selection of radiotherapy treatment for hepatocellular carcinomaComparison between chemoembolization combined with radiotherapy and chemoembolization alone for large hepatocellular carcinoma.External beam radiotherapy for unresectable hepatocellular carcinoma, an international multicenter phase I trial, SAKK 77/07 and SASL 26Dosimetric parameter predicting the deterioration of hepatic function after helical tomotherapy in patients with unresectable locally advanced hepatocellular carcinoma.Bromodeoxyuridine inhibits cancer cell proliferation in vitro and in vivo.Application of Radiotherapeutic Strategies in the BCLC-Defined Stages of Hepatocellular CarcinomaRadiotherapy and chemotherapy as therapeutic strategies in extrahepatic biliary duct carcinoma.Chinese guidelines for the diagnosis and comprehensive treatment of hepatic metastasis of colorectal cancer.Radiotherapeutic strategies in the management of hepatocellular carcinoma.Stereotactic body radiation therapy (SBRT) for definitive treatment and as a bridge to liver transplantation in early stage inoperable Hepatocellular carcinoma.Enhancement of tumor radioresponse by combined chemotherapy in murine hepatocarcinoma.The Safety and Efficacy of Combination Therapy of Sorafenib and Radiotherapy for Advanced Hepatocellular Carcinoma: A Retrospective Study.Evaluation of response after stereotactic body radiotherapy for hepatocellular carcinoma.
P2860
Q33409555-3B1F129B-F151-45F4-8BA3-6554F31E20B6Q34771239-947403DE-E357-48C7-9E94-C66683750B13Q35457074-0C1D8650-FC42-4329-9AD0-A38FFC108375Q35931183-F083311C-1276-4CDD-8119-5ADFD03E93BFQ36178891-7C7EEE43-CAAF-4FEB-B163-C67B90A02B9DQ36249520-6ADB310A-2647-4147-994B-82D4953046E5Q36555907-034507D2-5573-4396-9D30-C0E37521F644Q36825162-607ED6C6-47A7-4FB6-A10C-1B216ADE0B35Q37140658-423AE721-D7A7-47D8-A4D4-DF869C86A402Q37817003-90C88956-AF13-431A-B8C4-5EBDC3D119A9Q37907117-DFDD5267-C24B-4D37-805F-F1D320EEABA6Q37972813-8281A8EA-249E-4649-A049-C238CEAD1946Q42669016-BCCF6168-DBCA-4527-B3AE-CABED7F46590Q43736082-A8922899-B774-486C-BAC0-63692DC00F8AQ49567283-F64C22C6-BD79-4A9F-A0C4-412F80638935Q50998284-FCFE0D20-7926-4015-A171-BDB511DFFA4C
P2860
A phase I trial of hepatic arterial bromodeoxyuridine and conformal radiation therapy for patients with primary hepatobiliary cancers or colorectal liver metastases.
description
1997 nî lūn-bûn
@nan
1997 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
A phase I trial of hepatic art ...... r colorectal liver metastases.
@ast
A phase I trial of hepatic art ...... r colorectal liver metastases.
@en
type
label
A phase I trial of hepatic art ...... r colorectal liver metastases.
@ast
A phase I trial of hepatic art ...... r colorectal liver metastases.
@en
prefLabel
A phase I trial of hepatic art ...... r colorectal liver metastases.
@ast
A phase I trial of hepatic art ...... r colorectal liver metastases.
@en
P2093
P1476
A phase I trial of hepatic art ...... r colorectal liver metastases.
@en
P2093
Ensminger WD
Kessler ML
Lawrence TS
Robertson JM
P304
P356
10.1016/S0360-3016(97)00550-6
P407
P577
1997-12-01T00:00:00Z